PerkinElmer Inc. has agreed to acquire EUROIMMUN Medical Laboratory Diagnostics AG, a German multinational specializing in autoimmune, infectious disease and allergy testing.
One key benefit for PerkinElmer from the $1.3bn all-cash deal is the Waltham, Mass., firm will significantly grow its geographic reach outside the US. Of the about $310m in revenue...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?